Matches in SemOpenAlex for { <https://semopenalex.org/work/W2602658142> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2602658142 abstract "e15120 Background: Sipuleucel-T is an autologous cellular immunotherapy approved for asymptomatic or minimally symptomatic mCRPC. Three phase III sipuleucel-T trials (D9901, D9902A and D9902B [IMPACT]) allowed control patients (pts) to receive salvage treatment with an autologous product derived from previously frozen cells (APC8015F). We previously reported that salvage therapy with APC8015F demonstrated no deleterious effect and may have improved outcomes in control pts, potentially reducing the observed survival benefit seen with sipuleucel-T. Thus, we performed an exploratory analysis of pooled data from phase III studies to estimate the impact of APC8015F treatment on the OS benefit conferred by sipuleucel-T. Methods: We analyzed the effect of salvage APC8015F therapy on OS, and used a rank-preserving structural failure time (RPSFT) model to estimate control arm OS if treatment with APC8015F had not occurred. This allows estimation of the effect of sipuleucel-T treatment on OS, adjusting for salvage effect. Results: Median OS from randomization in the three pooled trials was 25.4 months with sipuleucel-T (n=488) and 21.5 months with control (n=249). Of the control arm pts, 165 (66.3%) subsequently received APC8015F. Median OS from randomization in the control population was 23.6 months for pts receiving APC8015F and 12.7 months for those who did not. Using the RPSFT model, and assuming APC8015F was as effective as sipuleucel-T, the estimate of median OS for control pts was 17.3 months, representing an 8.1 month median increase in OS with sipuleucel-T. Results from extensions of the RPSFT model, where APC8015F is assumed to have less treatment effect than sipuleucel-T, will be presented. Conclusions: These analyses estimated a median OS benefit for sipuleucel-T between 3.9 and 8.1 months, assuming that APC8015F had either no efficacy or comparable efficacy to sipuleucel-T, respectively. The results suggest a possible greater treatment effect of sipuleucel-T than was reported in the three phase III studies. Future studies should account for potential crossover treatment bias as this may diminish estimates of OS benefit." @default.
- W2602658142 created "2017-04-07" @default.
- W2602658142 creator A5002963063 @default.
- W2602658142 creator A5013362255 @default.
- W2602658142 creator A5025294481 @default.
- W2602658142 creator A5032861872 @default.
- W2602658142 creator A5047408345 @default.
- W2602658142 creator A5071741514 @default.
- W2602658142 date "2012-05-20" @default.
- W2602658142 modified "2023-09-30" @default.
- W2602658142 title "Impact of salvage therapy with APC8015F on the overall survival (OS) benefit achieved with sipuleucel-T in three phase III studies of metastatic castrate-resistant prostate cancer (mCRPC)." @default.
- W2602658142 doi "https://doi.org/10.1200/jco.2012.30.15_suppl.e15120" @default.
- W2602658142 hasPublicationYear "2012" @default.
- W2602658142 type Work @default.
- W2602658142 sameAs 2602658142 @default.
- W2602658142 citedByCount "0" @default.
- W2602658142 crossrefType "journal-article" @default.
- W2602658142 hasAuthorship W2602658142A5002963063 @default.
- W2602658142 hasAuthorship W2602658142A5013362255 @default.
- W2602658142 hasAuthorship W2602658142A5025294481 @default.
- W2602658142 hasAuthorship W2602658142A5032861872 @default.
- W2602658142 hasAuthorship W2602658142A5047408345 @default.
- W2602658142 hasAuthorship W2602658142A5071741514 @default.
- W2602658142 hasConcept C121608353 @default.
- W2602658142 hasConcept C126322002 @default.
- W2602658142 hasConcept C126894567 @default.
- W2602658142 hasConcept C141071460 @default.
- W2602658142 hasConcept C143998085 @default.
- W2602658142 hasConcept C2776694085 @default.
- W2602658142 hasConcept C2777701055 @default.
- W2602658142 hasConcept C2777910003 @default.
- W2602658142 hasConcept C2780192828 @default.
- W2602658142 hasConcept C2780775027 @default.
- W2602658142 hasConcept C31760486 @default.
- W2602658142 hasConcept C535046627 @default.
- W2602658142 hasConcept C71924100 @default.
- W2602658142 hasConceptScore W2602658142C121608353 @default.
- W2602658142 hasConceptScore W2602658142C126322002 @default.
- W2602658142 hasConceptScore W2602658142C126894567 @default.
- W2602658142 hasConceptScore W2602658142C141071460 @default.
- W2602658142 hasConceptScore W2602658142C143998085 @default.
- W2602658142 hasConceptScore W2602658142C2776694085 @default.
- W2602658142 hasConceptScore W2602658142C2777701055 @default.
- W2602658142 hasConceptScore W2602658142C2777910003 @default.
- W2602658142 hasConceptScore W2602658142C2780192828 @default.
- W2602658142 hasConceptScore W2602658142C2780775027 @default.
- W2602658142 hasConceptScore W2602658142C31760486 @default.
- W2602658142 hasConceptScore W2602658142C535046627 @default.
- W2602658142 hasConceptScore W2602658142C71924100 @default.
- W2602658142 hasLocation W26026581421 @default.
- W2602658142 hasOpenAccess W2602658142 @default.
- W2602658142 hasPrimaryLocation W26026581421 @default.
- W2602658142 hasRelatedWork W2051729664 @default.
- W2602658142 hasRelatedWork W2068785421 @default.
- W2602658142 hasRelatedWork W2118999172 @default.
- W2602658142 hasRelatedWork W2218620360 @default.
- W2602658142 hasRelatedWork W2249095293 @default.
- W2602658142 hasRelatedWork W2318101661 @default.
- W2602658142 hasRelatedWork W2324938652 @default.
- W2602658142 hasRelatedWork W2560500500 @default.
- W2602658142 hasRelatedWork W2589198120 @default.
- W2602658142 hasRelatedWork W2590392578 @default.
- W2602658142 hasRelatedWork W2599069938 @default.
- W2602658142 hasRelatedWork W2792391697 @default.
- W2602658142 hasRelatedWork W2891002453 @default.
- W2602658142 hasRelatedWork W2906673642 @default.
- W2602658142 hasRelatedWork W2947893599 @default.
- W2602658142 hasRelatedWork W2998841491 @default.
- W2602658142 hasRelatedWork W3080569900 @default.
- W2602658142 hasRelatedWork W3162395554 @default.
- W2602658142 hasRelatedWork W3192431492 @default.
- W2602658142 hasRelatedWork W91773918 @default.
- W2602658142 isParatext "false" @default.
- W2602658142 isRetracted "false" @default.
- W2602658142 magId "2602658142" @default.
- W2602658142 workType "article" @default.